VAERS Explorer
Back to explore

Report #2841722

Received May 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
19 yrs
State
VA
Recovered
Unknown
Vaccinated
—
Onset
May 12, 2025
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
YFYELLOW FEVER (YF-VAX)SANOFI PASTEURUNKUK134AAOT / LA

Symptoms (2)

No adverse eventProduct preparation error

Symptom narrative

Merck sterile water was used to reconstitute the vaccine and that the vaccine was administered to a patient with no reported adverse event; Merck sterile water was used to reconstitute the vaccine and that the vaccine was administered to a patient with no reported adverse event; Initial information received on 14-May-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 19 years old female patient who was administered with Yellow Fever Vaccine - [Yf-Vax] which was reconstituted with merck sterile water with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Water for injection (Sterile water). On an unknown date, the patient received an unknown dose of suspect Yellow Fever Vaccine - Solution for injection (lot UK134AA, expiry date 30-Nov-2025; strength not reported) via subcutaneous route in the left arm for Immunisation and patient who was administered with Yellow Fever Vaccine - Yf-Vax] which was reconstituted with merck sterile water with no reported adverse event (product preparation error) and (poor quality product administered). Action taken was not applicable. Reportedly, wanted to know if they use Merck's sodium chloride diluent, will it affect the vaccine. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Other medications

Sterile water